Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot that discusses obesity

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded weight loss drugs.

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.

There’s an obesity epidemic and we feel we can bring a ton of awareness to people through the Super Bowl,” said Dan Kenger, chief design officer at Hims & Hers. “There are very few live TV events that we as America all come around and congregate for and this provides a good platform to get that message out there.

Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."